Autopsy report · NCT00633568

Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow recruitment”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 2 months after it had already started.
Ran for about 8 years 1 month before it stopped.
125 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 3
Sponsor: European Lung Cancer Working Party
Sponsor type: University, hospital or other
Conditions: Non-small Cell Lung Carcinoma
Interventions: Concomitant Radiochemotherapy - Radiotherapy 66 Gy, Cisplatin, and Docetaxel; Concomitant Chemoradiotherapy - Radiotherapy 66 Gy, Cisplatin, and Docetaxel
Participants: 125
Sites: 19
Countries: Belgium, France, Greece, Spain

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.